ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Zhejiang Starry Pharm (603520.SHG)
Zhejiang Starry Pharm stock price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - Specialty & Generic · Shanghai Stock Exchange · China
CN¥7.77▼ -3.72%
Prices as of Oct 27, 2026 · CNY
Chance of rising in 1 month
51%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Zhejiang Starry Pharm in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Zhejiang Starry Pharm
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Zhejiang Starry Pharm a 51% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between CN¥7.36 and CN¥8.23; in 9 out of 10, between CN¥6.66 and CN¥9.09. Estimated annual volatility is 29%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- CN¥3.5B
- Market cap (USD)
- $529M
- P/E ratio
- 201.3
- Dividend yield
- 3.70%
- 52-week high
- CN¥14.37
- 52-week low
- CN¥7.64
- Revenue (12 months)
- CN¥2.5B
- Gross margin
- 19.0%
- Operating margin
- 2.1%
- Net margin
- 0.9%
- Beta
- 0.51
What this means
ATLAS does not publish a fair value for 603520.SHG right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks 603520.SHG has traded between CN¥7.64 and CN¥14.37. Today it is 45.9% below that high and 2% above its low.
On the business: net margin is 0.9%; it trades at 201.3 times earnings.
Its beta is 0.51: it tends to move less than the market.
About the company
Zhejiang Starry Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of active pharmaceutical ingredients in China and internationally. It operates through Contrast Agent Series, Quinolone Series, CMO/CDMO, and Others segments.
Want to see everything about Zhejiang Starry Pharm?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Zhejiang Starry Pharm do?
Zhejiang Starry Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of active pharmaceutical ingredients in China and internationally. It operates through Contrast Agent Series, Quinolone Series, CMO/CDMO, and Others segments.
What is the chance 603520.SHG goes up next month?
51%: close to a coin flip. In half of the simulated outcomes, 603520.SHG ends the month between CN¥7.36 and CN¥8.23.
How big is Zhejiang Starry Pharm and what is its P/E ratio?
Zhejiang Starry Pharm's market capitalization is CN¥3.5B. Its price-to-earnings (P/E) ratio is 201.3: you pay CN¥201.3 for each CN¥1.00 of yearly earnings.
Does Zhejiang Starry Pharm pay a dividend?
Yes. 603520.SHG's current dividend yield is 3.70% at today's price (CN¥7.77).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer